Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

105 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Locally available heparin modulates inflammatory cell recruitment in a manner independent of anticoagulant activity.
Lever R, Smailbegovic A, Page CP. Lever R, et al. Eur J Pharmacol. 2010 Mar 25;630(1-3):137-44. doi: 10.1016/j.ejphar.2009.12.015. Epub 2009 Dec 30. Eur J Pharmacol. 2010. PMID: 20043903
The CRF-like peptide urocortin greatly attenuates loss of extracellular striatal dopamine in rat models of Parkinson's disease by activating CRF(1) receptors.
Abuirmeileh A, Harkavyi A, Kingsbury A, Lever R, Whitton PS. Abuirmeileh A, et al. Among authors: lever r. Eur J Pharmacol. 2009 Feb 14;604(1-3):45-50. doi: 10.1016/j.ejphar.2008.11.009. Epub 2008 Nov 13. Eur J Pharmacol. 2009. PMID: 19026631
The corticotrophin-releasing factor-like peptide urocortin reverses key deficits in two rodent models of Parkinson's disease.
Abuirmeileh A, Lever R, Kingsbury AE, Lees AJ, Locke IC, Knight RA, Chowdrey HS, Biggs CS, Whitton PS. Abuirmeileh A, et al. Among authors: lever r. Eur J Neurosci. 2007 Jul;26(2):417-23. doi: 10.1111/j.1460-9568.2007.05653.x. Eur J Neurosci. 2007. PMID: 17650114
Exendin-4 reverts behavioural and neurochemical dysfunction in a pre-motor rodent model of Parkinson's disease with noradrenergic deficit.
Rampersaud N, Harkavyi A, Giordano G, Lever R, Whitton J, Whitton P. Rampersaud N, et al. Among authors: lever r. Br J Pharmacol. 2012 Dec;167(7):1467-79. doi: 10.1111/j.1476-5381.2012.02100.x. Br J Pharmacol. 2012. PMID: 22774922 Free PMC article. Retracted.
The effects of heparin and related molecules upon the adhesion of human polymorphonuclear leucocytes to vascular endothelium in vitro.
Lever R, Hoult JR, Page CP. Lever R, et al. Br J Pharmacol. 2000 Feb;129(3):533-40. doi: 10.1038/sj.bjp.0703099. Br J Pharmacol. 2000. PMID: 10711352 Free PMC article.
HIT dynamics are Fab.
Lever R. Lever R. Trends Pharmacol Sci. 2000 Sep;21(9):330. doi: 10.1016/s0165-6147(00)01529-7. Trends Pharmacol Sci. 2000. PMID: 10973080 No abstract available.
Mast cell glycosaminoglycans.
Mulloy B, Lever R, Page CP. Mulloy B, et al. Among authors: lever r. Glycoconj J. 2017 Jun;34(3):351-361. doi: 10.1007/s10719-016-9749-0. Epub 2016 Nov 30. Glycoconj J. 2017. PMID: 27900574 Free PMC article. Review.
Size-fractionated heparins have differential effects on human neutrophil function in vitro.
Lever R, Lo WT, Faraidoun M, Amin V, Brown RA, Gallagher J, Page CP. Lever R, et al. Br J Pharmacol. 2007 Jul;151(6):837-43. doi: 10.1038/sj.bjp.0707298. Epub 2007 May 29. Br J Pharmacol. 2007. PMID: 17533420 Free PMC article.
Effect of tecastemizole on pulmonary and cutaneous allergic inflammatory responses.
Lever R, Hefni A, Moffatt JD, Paul W, Page CP. Lever R, et al. Clin Exp Allergy. 2007 Jun;37(6):909-17. doi: 10.1111/j.1365-2222.2007.02730.x. Clin Exp Allergy. 2007. PMID: 17517105
Glycosaminoglycans, airways inflammation and bronchial hyperresponsiveness.
Lever R, Page C. Lever R, et al. Pulm Pharmacol Ther. 2001;14(3):249-54. doi: 10.1006/pupt.2001.0296. Pulm Pharmacol Ther. 2001. PMID: 11448151 Review.
105 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback